| Product Code: ETC6662728 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Onychomycosis Drug Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Onychomycosis Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Onychomycosis Drug Market - Industry Life Cycle |
3.4 Canada Onychomycosis Drug Market - Porter's Five Forces |
3.5 Canada Onychomycosis Drug Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Canada Onychomycosis Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Canada Onychomycosis Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Canada Onychomycosis Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Canada Onychomycosis Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Canada Onychomycosis Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Canada Onychomycosis Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about onychomycosis and its treatment options |
4.2.2 Growing aging population in Canada |
4.2.3 Rising disposable income leading to increased healthcare spending |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative treatment options such as home remedies |
4.3.3 High cost associated with onychomycosis drug treatment |
5 Canada Onychomycosis Drug Market Trends |
6 Canada Onychomycosis Drug Market, By Types |
6.1 Canada Onychomycosis Drug Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Canada Onychomycosis Drug Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Canada Onychomycosis Drug Market Revenues & Volume, By Proximal Subungual, 2021- 2031F |
6.1.4 Canada Onychomycosis Drug Market Revenues & Volume, By Distal Subungual, 2021- 2031F |
6.1.5 Canada Onychomycosis Drug Market Revenues & Volume, By Candidal, 2021- 2031F |
6.1.6 Canada Onychomycosis Drug Market Revenues & Volume, By White Superficial, 2021- 2031F |
6.1.7 Canada Onychomycosis Drug Market Revenues & Volume, By Total Dystrophic, 2021- 2031F |
6.2 Canada Onychomycosis Drug Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Canada Onychomycosis Drug Market Revenues & Volume, By Griseofulvin, 2021- 2031F |
6.2.3 Canada Onychomycosis Drug Market Revenues & Volume, By Ketoconazole, 2021- 2031F |
6.2.4 Canada Onychomycosis Drug Market Revenues & Volume, By Ciclopirox, 2021- 2031F |
6.2.5 Canada Onychomycosis Drug Market Revenues & Volume, By Terbinafine, 2021- 2031F |
6.2.6 Canada Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Onychomycosis Drug Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Canada Onychomycosis Drug Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 Canada Onychomycosis Drug Market Revenues & Volume, By Topical Therapy, 2021- 2031F |
6.3.4 Canada Onychomycosis Drug Market Revenues & Volume, By Debridement, 2021- 2031F |
6.4 Canada Onychomycosis Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Onychomycosis Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Canada Onychomycosis Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.4 Canada Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada Onychomycosis Drug Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Canada Onychomycosis Drug Market Revenues & Volume, By Direct, 2021- 2031F |
6.5.3 Canada Onychomycosis Drug Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Canada Onychomycosis Drug Market Revenues & Volume, By Retailers and, 2021- 2031F |
6.5.5 Canada Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Onychomycosis Drug Market, By End Users |
6.6.1 Overview and Analysis |
6.6.2 Canada Onychomycosis Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Canada Onychomycosis Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Canada Onychomycosis Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 Canada Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Onychomycosis Drug Market Import-Export Trade Statistics |
7.1 Canada Onychomycosis Drug Market Export to Major Countries |
7.2 Canada Onychomycosis Drug Market Imports from Major Countries |
8 Canada Onychomycosis Drug Market Key Performance Indicators |
8.1 Number of prescriptions for onychomycosis drugs |
8.2 Patient adherence rates to prescribed treatment regimens |
8.3 Number of dermatologist visits for onychomycosis treatment |
9 Canada Onychomycosis Drug Market - Opportunity Assessment |
9.1 Canada Onychomycosis Drug Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Canada Onychomycosis Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Canada Onychomycosis Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Canada Onychomycosis Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Canada Onychomycosis Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Canada Onychomycosis Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Canada Onychomycosis Drug Market - Competitive Landscape |
10.1 Canada Onychomycosis Drug Market Revenue Share, By Companies, 2024 |
10.2 Canada Onychomycosis Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here